Recruiting NA Bilingualism

New treatment option for Bilingualism

Official title Word Learning in Bilingual Typical and Late Talking Children: The Role of Meaning and Input

ClinicalTrials.gov ID: NCT07600242

What this study is testing

What it's testing
The goal of this clinical trial is to understand how different types of word categories, along with the language children hear from their parents, support bilingual toddlers' word learning. This study will address two main questions: (1) How are the words toddlers know related to the words their parents use?

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 24 to 30. Healthy volunteers may be eligible.

You may be able to join if

  • At least 10% exposure to both English and Spanish or at least 90% exposure to English and another language

You likely can't join if

  • Hearing impairment
  • Uncorrected visual impairment
  • Neurological impairment
  • Genetic syndromes
  • Neurodevelopmental disabilities (e.g. autism)
  • More than 10% exposure to a language other than English or Spanish

The study team makes the final eligibility decision.

Where it's taking place

  • Boston, Massachusetts, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 24 months to 30 months. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.